KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Dividends Paid - Common (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Dividends Paid - Common for 17 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Dividends Paid - Common rose 3.61% to $1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.0 billion, a 3.74% increase, with the full-year FY2025 number at $5.0 billion, up 3.74% from a year prior.
  • Dividends Paid - Common was $1.3 billion for Q4 2025 at Bristol Myers Squibb, roughly flat from $1.3 billion in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $1.3 billion in Q3 2025 to a low of $8.0 million in Q2 2021.
  • A 5-year average of $1.1 billion and a median of $1.2 billion in 2023 define the central range for Dividends Paid - Common.
  • Peak YoY movement for Dividends Paid - Common: tumbled 99.22% in 2021, then skyrocketed 9875.0% in 2023.
  • Bristol Myers Squibb's Dividends Paid - Common stood at $1.1 billion in 2021, then rose by 4.19% to $1.1 billion in 2022, then grew by 1.31% to $1.2 billion in 2023, then grew by 5.0% to $1.2 billion in 2024, then grew by 3.61% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Dividends Paid - Common are $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025).